Advertisement
LumiraDx Limited (LMDX)
NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Follow
As of 04:00PM EST. Market open.
| Previous Close | 0.0160 |
| Open | 0.0211 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0151 - 0.0282 |
| 52 Week Range | 0.0151 - 0.0282 |
| Volume | |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireLumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th
LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX)(the “Company”) today announced that it has received notification from The Nasdaq Stock Market LLC (“Nasdaq”) that its securities will be suspended from trading at the open of business on January 9, 2024 as a result of the Company’s failure to maintain compliance with Nasdaq’s continued listing standards. As previously disclosed, on October 24, 2023, the Company received a notice from Nasdaq’s Listing Qualifications Departm
MedTech DiveRoche to buy LumiraDx’s point-of-care technology for $295M
LumiraDx faces financial pressures amid declining test sales and a potential delisting from the Nasdaq.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.